ATS 2019 Virtual Final Program

9:15 A Patient's Perspective R. Haskin, Houston, TX 9:20 Inflammation in Bronchiectasis J.D. Chalmers, MD, PhD, Dundee, United Kingdom 9:40 Microbiome and Mycobiome K.L. Winthrop, MD, MPH, Portland, OR 10:00 Genetics in Bronchiectasis and NTM K.N. Olivier, MD, MPH, Bethesda, MD 10:20 Phenotyping Bronchiectasis G. Tino, MD, ATSF, Philadelphia, PA 10:40 Update in the National Bronchiectasis and Research Registry and Strategies for Future Clinical Trials A.E. O'Donnell, MD, Washington, DC 11:00 Panel Discussion This session and the International Conference are supported by an educational grant from Insmed Incorporated All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 MOC Points Available: 2 C9 DIFFICULT TO TREAT AND SEVERE ASTHMA IN THE PEDIATRIC POPULATION Assemblies on Pediatrics; Allergy, Immunology and Inflammation 9:15 a.m. - 11:15 a.m. OMNI DALLAS DOWNTOWN Dallas Ballroom A-C (Level 3) Target Audience Pediatricians, pediatric pulmonologists, pediatric intensivists, adult asthma specialists Objectives At the conclusion of this session, the participant will be able to: • distinguish severe treatment refractory asthma from difficult to treat asthma; • have new strategies to manage the care of children with difficult to treat asthma; • learn new findings about the evaluation and treatment options for difficult to treat asthma. This session will cover various aspects of difficult to treat asthma including cutting edge therapeutics. This session will be of interest to clinicians who care for children with asthma, as well as researchers in this field. This session will address the following topics: asthma comorbidities, medication adherence, biologic therapies, and the use of bronchoscopy in children with asthma. Chairing: H. Hoch, MD, Aurora, CO S.J. Szefler, MD, Aurora, CO M. Kattan, MD, New York, NY 9:15 Introduction S.J. Szefler, MD, Aurora, CO 9:19 A Patient's Perspective M. Papazis, MD, Washington, IL 9:24 Immune Dysfunction in Children with Obese Asthma D. Rastogi, MBBS, MS, Bronx, NY 9:53 The Role of Medication Adherence in Difficult to Treat Asthma in Children H. Hoch, MD, Aurora, CO 10:17 The Use of Biologic Therapies in Childhood Asthma S. Lovinsky-Desir, MD, New York, NY 10:46 Bronchoscopy in the Diagnosis and Management of Asthm a A. Vicencio, MD, New York, NY This session and the International Conference are supported by educational grants from Genentech, Inc., Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. BEHAVIORAL • CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 C10 LIFESPAN WEIGHT MANAGEMENT OF SLEEP DISORDERS: REAL, FEASIBLE OR JUST THEORY? Assembly on Sleep and Respiratory Neurobiology 9:15 a.m. - 11:15 a.m. KBHCCD Room D221/D225/D226 (Level 2) Target Audience Pulmonologists, respiratory therapists, clinical and basic researchers, primary care practitioners, and other health professionals who are interested in treating patients with sleep apnea and obesity Objectives At the conclusion of this session, the participant will be able to: • understand the challenges in pursuing a successful long-term weight management in the pandemic obesity; • recognize the role of weight management in OSA, from kids to humans; • understand the potential role of sleep extension in reversing weight gain and metabolic dysfunction in sleep-deprived patients. This proposal is intending to be a comprehensive major symposium discussing the evidence of lifestyle interventions, anti-obesity drugs and bariatric surgery on obstructive sleep apnea (OSA) and obesity hypoventilation syndrome. Distinct talks will address the evidence in kids, adolescents and adults. Moreover, this session will have the opportunity to discuss recent evidence on the potential role of sleep extension on weight and metabolic outcomes in sleep-deprived patients. Chairing: B.A. Edwards, PhD, Melbourne, Australia L. Kheirandish-Gozal, MD, MSc, ATSF, Columbia, MO B. Mokhlesi, MD, MSc, Chicago, IL L.F. Drager, MD, Sao Paulo, Brazil 9:15 Challenges in the Long-Term Weight Management in the Pandemic Obesity: Is There Light at the End of the Tunnel? J.P. Despres, PhD, Quebec, Canada ATS 2019 • Dallas, TX TUESDAY • MAY 21 225 TUESDAY MORNING